Merger & Acquisition(M&A)

The definitive merger between NextCure, Inc. And Avere Therapeutics, Inc. Creates a new entity, Avere Therapeutics, Inc. Trading under the ticker AVRX. The transaction delivers a $320 million cash infusion, positioning the combined company to advance its once‑weekly oral IL‑23 antagonist, AVR‑001, through late‑stage …

A proposed merger between two leading entertainment companies is advancing toward completion, even as state attorneys general pursue legal action to block the transaction. The lawsuit alleges the deal would create an entity with excessive market influence, potentially reducing competition in the media environment.

RE/MAX Holdings, Inc. (NYSE: RMAX) announced that the U.S. Department of Justice completed its review of the proposed merger with The Real Brokerage and related entities on July 13. This development removes a key regulatory hurdle, bringing the companies closer to finalizing their combination.

Shell’s $16.4 billion acquisition of ARC cleared a critical milestone as shareholders approved the deal, signaling a potential shift in the energy sector’s competitive environment. The move is poised to bolster Shell’s production capacity and reshape market expectations for oil and gas assets, with …

Discovery. The legal challenge sent Paramount Skydance shares lower while providing a slight lift to Warner Bros. Discovery, signaling investor unease over regulatory hurdles.

Catalyst Bancorp (NASDAQ: CLST) has officially completed its acquisition of Lakeside Bancshares, reinforcing its position in the Louisiana banking sector. The transaction was executed through a cash-based share exchange, culminating in the merger of the two institutions.

NextCure, Inc. (NASDAQ: NXTC) filed a formal agreement to combine with Avere Therapeutics, Inc. The merger will occur through a two‑entity structure that consolidates Avere into a wholly owned subsidiary of NextCure, followed by a second step that merges the subsidiary into a different …